Cytomx Thera (CTMX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2018 | 09-2018 | 06-2018 | 03-2018 | 12-2017 | |
| Sales | 11,471 | 12,509 | 21,338 | 14,184 | 27,074 |
| Gross Profit | 11,471 | 12,509 | 21,338 | 14,184 | 27,074 |
| Operating Expenses | 37,281 | 35,686 | 34,595 | 29,814 | 28,321 |
| Operating Income | -25,810 | -23,177 | -13,257 | -15,630 | -1,247 |
| Interest Expense | 0 | 0 | 0 | 140 | 0 |
| Other Income | 2,489 | 2,248 | 1,601 | 1,375 | 1,349 |
| Pre-tax Income | -23,321 | -20,929 | -11,656 | -14,395 | 102 |
| Income Tax | 8,912 | 2,502 | 1,791 | 1,098 | -519 |
| Net Income Continuous | -32,233 | -23,431 | -13,447 | -15,493 | 621 |
| Net Income | $-32,233 | $-23,431 | $-13,447 | $-15,493 | $621 |
| EPS Basic Total Ops | -0.75 | -0.53 | -0.35 | -0.40 | 0.04 |
| EPS Basic Continuous Ops | -0.75 | -0.53 | -0.35 | -0.40 | 0.03 |
| EPS Diluted Total Ops | -0.75 | -0.53 | -0.35 | -0.40 | 0.04 |
| EPS Diluted Continuous Ops | -0.75 | -0.53 | -0.35 | -0.40 | 0.03 |
| EBITDA(a) | $-25,898 | $-23,138 | $-13,176 | $-15,479 | $-847 |